Coupled equilibria of dimerization and lipid binding modulate SARS Cov 2 Orf9b interactions and interferon response.
Saved in:
| Title: | Coupled equilibria of dimerization and lipid binding modulate SARS Cov 2 Orf9b interactions and interferon response. |
|---|---|
| Authors: | Felipe CS; Department of Bioengineering and Therapeutic Sciences, University of Caliafornia San Francisco, San Francisco, CA 94158., Batra J; Quantitative Biosciences Institute, University of California San Francisco, San Francisco, CA 94158.; Gladstone Institute of Data Science and Biotechnology, J. David Gladstone Institutes, San Francisco, 94158, California,USA.; Department of Cellular and Molecular Pharmacology,University of California San Francisco, San Francisco, CA 94158., Muralidharaan M; Quantitative Biosciences Institute, University of California San Francisco, San Francisco, CA 94158.; Gladstone Institute of Data Science and Biotechnology, J. David Gladstone Institutes, San Francisco, 94158, California,USA.; Department of Cellular and Molecular Pharmacology,University of California San Francisco, San Francisco, CA 94158., Malpotra S; Quantitative Biosciences Institute, University of California San Francisco, San Francisco, CA 94158.; Gladstone Institute of Data Science and Biotechnology, J. David Gladstone Institutes, San Francisco, 94158, California,USA.; Department of Cellular and Molecular Pharmacology,University of California San Francisco, San Francisco, CA 94158., Anand D; Quantitative Biosciences Institute, University of California San Francisco, San Francisco, CA 94158.; Gladstone Institute of Data Science and Biotechnology, J. David Gladstone Institutes, San Francisco, 94158, California,USA.; Department of Cellular and Molecular Pharmacology,University of California San Francisco, San Francisco, CA 94158., Bauer R; Quantitative Biosciences Institute, University of California San Francisco, San Francisco, CA 94158.; Department of Cellular and Molecular Pharmacology,University of California San Francisco, San Francisco, CA 94158., Verba KA; Quantitative Biosciences Institute, University of California San Francisco, San Francisco, CA 94158.; Department of Cellular and Molecular Pharmacology,University of California San Francisco, San Francisco, CA 94158., Swaney DL; Quantitative Biosciences Institute, University of California San Francisco, San Francisco, CA 94158.; Gladstone Institute of Data Science and Biotechnology, J. David Gladstone Institutes, San Francisco, 94158, California,USA.; Department of Cellular and Molecular Pharmacology,University of California San Francisco, San Francisco, CA 94158., Krogan NJ; Quantitative Biosciences Institute, University of California San Francisco, San Francisco, CA 94158.; Gladstone Institute of Data Science and Biotechnology, J. David Gladstone Institutes, San Francisco, 94158, California,USA.; Department of Cellular and Molecular Pharmacology,University of California San Francisco, San Francisco, CA 94158., Grabe M; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA 94158., Fraser JS; Department of Bioengineering and Therapeutic Sciences, University of Caliafornia San Francisco, San Francisco, CA 94158.; Quantitative Biosciences Institute, University of California San Francisco, San Francisco, CA 94158. |
| Source: | BioRxiv : the preprint server for biology [bioRxiv] 2025 Aug 01. Date of Electronic Publication: 2025 Aug 01. |
| Publication Type: | Journal Article; Preprint |
| Journal Info: | Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
